公司資料
Globus Medical 股價、新聞與催化劑
- 股票代碼:
- GMED
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
85.12 USD (-0.91%)
收盤價
最後更新: 2026年8月17日
10.6B USD
市值
股價為何變動
As of Aug 17, 2026, GMED closed down 0.91% at $85.12. No new same-company headline was identified in the current news window.
公司概覽
Musculoskeletal Technology
Globus Medical develops products and technologies for musculoskeletal care. Its portfolio covers spinal surgery, orthopedic trauma, joint reconstruction and neuromodulation.
Implants and Enabling Technologies
The company sells implants, instruments and biologics across spine, orthopedic trauma and joint-reconstruction procedures.
Enabling Technologies
Globus provides navigation, imaging and robotic systems that support surgical planning and execution. These technologies create a broader procedural ecosystem around its implant portfolio.
Expanded Pain-Management Platform
Through Nevro, Globus also participates in spinal-cord stimulation and other neuromodulation therapies for chronic pain, broadening the company beyond its traditional spine and orthopedic markets.
未來催化劑
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。